ARCHIVES

DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting

This article is from The Cancer Letter archive.

Vol. 08 No. 11 | March 12, 1982

Download PDF Visit The Full Archive

Related Articles

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

Radium Society To Meet In L.A.

March 2, 1979

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009